{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:15:34Z","timestamp":1789676134895,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hoc.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:14:51Z","timestamp":1762928091000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Contemporary Approaches to Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Alexa J.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria D.","family":"McDow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley E.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hoc.2025.07.003_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.hoc.2025.07.003_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.hoc.2025.07.003_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.hoc.2025.07.003_bib4","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2025.07.003_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"17","key":"10.1016\/j.hoc.2025.07.003_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2025.07.003_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00423-010-0698-y","article-title":"Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade","volume":"395","author":"Miller","year":"2010","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"3","key":"10.1016\/j.hoc.2025.07.003_bib8","doi-asserted-by":"crossref","first-page":"101434","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.hoc.2025.07.003_bib9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2025.07.003_bib10","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.surg.2014.08.018","article-title":"A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I\/II disease","volume":"156","author":"Asare","year":"2014","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.hoc.2025.07.003_bib11","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-18-0608","article-title":"European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.hoc.2025.07.003_bib13","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1245\/s10434-018-6749-2","article-title":"Evaluation, staging, and surgical management for adrenocortical carcinoma: an update from the SSO endocrine and head and neck disease site working group","volume":"25","author":"Dickson","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2025.07.003_bib14","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.hoc.2025.07.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ecl.2015.02.007","article-title":"Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis","volume":"44","author":"Nakamura","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.hoc.2025.07.003_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080909","article-title":"Surgical management of adrenocortical carcinoma: current highlights","volume":"9","author":"Cavallaro","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.hoc.2025.07.003_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00292-010-1306-1","article-title":"[Current TNM classification systems for adrenocortical carcinoma]","volume":"31","author":"Fassnacht","year":"2010","journal-title":"Pathologe"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/a-2042-2431","article-title":"A revised version of the TNM classification leads to optimized predictive performance in patients with adrenocortical carcinoma","volume":"55","author":"David","year":"2023","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.hoc.2025.07.003_bib19","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.10414","article-title":"European society of endocrine surgeons (ESES) and European network for the study of adrenal tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma","volume":"104","author":"Gaujoux","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.hoc.2025.07.003_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1245\/s10434-018-6999-z","article-title":"Patterns of lymph node recurrence in adrenocortical carcinoma: possible implications for primary surgical treatment","volume":"26","author":"Reibetanz","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40618-015-0422-4","article-title":"Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?","volume":"39","author":"Porpiglia","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.hoc.2025.07.003_bib23","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.surg.2012.08.024","article-title":"Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy","volume":"152","author":"Miller","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.hoc.2025.07.003_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00423-023-02997-z","article-title":"Minimally invasive versus open adrenalectomy for adrenocortical carcinoma: the keys surgical factors influencing the outcomes-a collective overview","volume":"408","author":"Giordano","year":"2023","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"1","key":"10.1016\/j.hoc.2025.07.003_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bju.13592","article-title":"International consultation on urological diseases and European association of urology international consultation on minimally invasive surgery in urology: laparoscopic and robotic adrenalectomy","volume":"119","author":"Ball","year":"2017","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.hoc.2025.07.003_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/08941939.2014.987886","article-title":"Laparoscopic versus open adrenalectomy for stage I\/II adrenocortical carcinoma: meta-analysis of outcomes","volume":"28","author":"Sgourakis","year":"2015","journal-title":"J Invest Surg"},{"issue":"3","key":"10.1016\/j.hoc.2025.07.003_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/fon-2017-0420","article-title":"Minimally invasive adrenal surgery: virtue or vice?","volume":"14","author":"Winoker","year":"2018","journal-title":"Future Oncol"},{"issue":"19","key":"10.1016\/j.hoc.2025.07.003_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195754","article-title":"Surgical management of adrenocortical carcinoma: a literature review","volume":"11","author":"Rossi","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ajur.2023.04.001","article-title":"Robot-assisted adrenalectomy: step-by-step technique and surgical outcomes at a high-volume robotic center","volume":"10","author":"Piramide","year":"2023","journal-title":"Asian J Urol"},{"issue":"10","key":"10.1016\/j.hoc.2025.07.003_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.hoc.2025.07.003_bib31","article-title":"Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options","volume":"2","author":"Al-Ward","year":"2022","journal-title":"Endocr Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2025.07.003_bib33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00268-014-2484-4","article-title":"Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy","volume":"38","author":"Bednarski","year":"2014","journal-title":"World J Surg"},{"issue":"23","key":"10.1016\/j.hoc.2025.07.003_bib34","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2025.07.003_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.hoc.2025.07.003_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211038409","article-title":"Management of adrenocortical carcinoma: are we making progress?","volume":"13","author":"Kiesewetter","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41416-022-02082-0","article-title":"Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma","volume":"128","author":"Kimpel","year":"2023","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2025.07.003_bib38","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","article-title":"Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma","volume":"91","author":"Fassnacht","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.hoc.2025.07.003_bib39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/cancers16040706","article-title":"The value of local therapies in advanced adrenocortical carcinoma","volume":"16","author":"Kimpel","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.hoc.2025.07.003_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/a-2209-6022","article-title":"Current evidence on local therapies in advanced adrenocortical carcinoma","volume":"56","author":"Kimpel","year":"2024","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.hoc.2025.07.003_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ejendo\/lvae022","article-title":"Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma","volume":"190","author":"Lippert","year":"2024","journal-title":"Eur J Endocrinol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:16:13Z","timestamp":1762928173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858825000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0889858825000905"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2025.07.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Approaches to Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}